Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new ...

Researchers conducted a retrospective study using data from 182 subjects with high-risk recurrent prostate cancers.

Apalutamide is under clinical development by Johnson & Johnson and currently in Phase II for Prostate Cancer. According to GlobalData, Phase II drugs for Prostate Cancer have a 23% phase transition ...

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk ...

The findings show that more extensive research on how pesticides impact the development and severity of various cancers is ...

After a year beset with illness, Te Pāti Māori's former co-leader urges New Zealanders to take their wellbeing seriously ...

King Charles III was diagnosed with cancer earlier this year after a hospital visit for an enlarged prostate. This is how treatment is going.

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

Scientists at Indiana University School of Medicine have discovered a new way to attack prostate cancer by cutting off its ...